logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Massimo Cristofanilli

division of hematology-oncology

111H-index
1.4KPaper Count
5.7WCitation Count
Published Papers 433
Publication Date
logo
Inflammatory breast cancer: Improving research and care through the integration of preclinical evidence and technological advances
errCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
IF5.6
err2026-08-06
err0
PREAI
errEleonora Nicolo`; Maroua Manai; Amr Soliman; Carolina Reduzzi; Massimo Cristofanilli
errShare
errSave
Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial
errLancet Oncology
IF35.9
err2026-07-13
err0
PREAI
errNicholas C Turner; Erica L Mayer; Yeon Hee Park; Wolfgang Janni; Cynthia Ma; Massimo Cristofanilli; Giampaolo Bianchini; Kevin Kalinsky; Hiroji Iwata; Stephen Chia; Adam M Brufsky; Peter A Fasching; Zbigniew Nowecki; Javier Pascual; Nuri Karadurmus; Einav Gal-Yam; Wei-Pang Chung; Seock-Ah Im; Alberto Zambelli; Florence Dalenc
errShare
errSave
International expert consensus on the clinical integration of circulating tumor cells in solid tumors
errEuropean Journal of Cancer
IF7.1
err2025-10-20
err0
PREAI
errEleonora Nicolò; Carolina Reduzzi; Jean-Yves Pierga; Paola Gazzaniga; Nikolas H. Stoecklein; Valeria Denninghoff; Dominic G. Rothwell; Johann S. De Bono; Dario Marchetti; Evi Lianidou; Sabine Riethdorf; Daniele Generali; Paul Hofman; Lorenzo Gerratana; Peter Kuhn; Jean Paul Thiery; Michail Ignatiadis; Francois-Clement Bidard; Anthony Lucci; Sabine Kasimir-Bauer; Maria Jose Serrano; Massimo Cristofanilli
errShare
errSave
Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy
errAnnals of Oncology
IF65.4
err2025-10-20
err0
errOAAI
errE.L. Mayer; F.-C. Bidard; Y.H. Park; W. Janni; C. Ma; M. Cristofanilli; H. Iwata; G. Bianchini; K. Kalinsky; S. Chia; A. Brufsky; P.A. Fasching; Z. Nowecki; S.-C. Chen; J. Pascual; L. Moreau; M. Ruiz-Borrego; A. Shai; N. Karadurmus; J.H. Sohn; Y. Zhu; I. Leddin; M.S. Miralles; C.H. Bartlett; N. Turner
errShare
errSave
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis
errJNCI CANCER SPECTRUM
IF4.1
err2025-10-01
err0
errOAAI
errSchettini, Francesco; Nucera, Sabrina; Di Grazia, Giuseppe; Giudici, Fabiola; Strina, Carla; Milani, Manuela; Tancredi, Richard; Conte, Benedetta; Criscitiello, Carmen; Giuliano, Mario; Lambertini, Matteo; Sanchez-Bayona, Rodrigo; Pascual, Tomas; Arpino, Grazia; Del Mastro, Lucia; Vigneri, Paolo; Cristofanilli, Massimo; Rugo, Hope S.; Gennari, Alessandra; Curigliano, Giuseppe; Generali, Daniele
errShare
errSave
Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis
errJOURNAL OF CLINICAL INVESTIGATION
IF13.6
err2025-09-16
err1
errOAAI
errScholten, David; El-Shennawy, Lamiaa; Jia, Yuzhi; Zhang, Youbin; Hyun, Elizabeth; Reduzzi, Carolina; Hoffmann, Andrew D.; Almubarak, Hannah F.; Tong, Fangjia; Dashzeveg, Nurmaa K.; Sun, Yuanfei; Squires, Joshua R.; Lu, Janice; Platanias, Leonidas C.; Wasserfall, Clive H.; Gradishar, William J.; Cristofanilli, Massimo; Fang, Deyu; Liu, Huiping
errShare
errSave
Phenotyping and Clinical Utility of Phagocytic Polyploid Giant Cancer Macrophages in Blood
errCancer Letters
IF10.1
err2025-09-03
err0
PREAI
errDaniel L. Adams; Massimo Cristofanilli; Steven H. Lin; Raymond C. Bergan; Thai H. Ho; Jeffrey R. Marks; Stuart S. Martin; Martin J. Edelman; Saranya Chumsri; Elizabeth J. Hager; Cha-Mei Tang; Susan Tsai; R. Katherine Alpaugh
errShare
errSave
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysis
errnpj Breast Cancer
IF7.6
err2025-08-16
err0
errOAAI
errLetizia Pontolillo; Andrew A. Davis; Lorenzo Gerratana; Arielle J. Medford; Judy Wang; Eleonora Nicolo’; Katherine Clifton; Marko Velimirovic; Surbhi Warrior; Emily Podany; Eleni Andreopoulou; Mara Serena Serafini; Laura Munoz-Arcos; Elisabetta Molteni; Marla Lipsyc-Sharf; Caterina Gianni; Nadia Bayou; Charles S. Dai; Diana Giannarelli; Emilio Bria; Cynthia X. Ma; Aditya Bardia; Carolina Reduzzi; Massimo Cristofanilli
errShare
errSave
Computational ranking identifies Plexin-B2 in circulating tumor cell clustering with monocytes in breast cancer metastasis
errNature Communications
IF15.7
err2025-08-16
err0
errOAAI
errEmma Schuster; Nurmaa K. Dashzeveg; Fangjia Tong; Yuzhi Jia; Lamiaa El-Shennawy; Tong Zhang; Andrew D. Hoffman; Reta Birhanu Kitata; Golam Kibria; Youbin Zhang; Joshua R. Squires; Chunlei Zheng; Erika Ramos; Rokana Taftaf; David Scholten; Hannah F. Almubarak; Valery Adorno-Cruz; David P. Sullivan; Carolina Reduzzi; Allegra C. Minor; William Purev-Ochir; Sabina Spahija; Rong Xu; Kalliopi P. Siziopikou; Leonidas C. Platanias; Ami Shah; William A. Muller; William J. Gradishar; Massimo Cristofanilli; Chia-Feng Tsai; Tujin Shi; Huiping Liu
errShare
errSave
Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancer☆
errESMO Open
IF8.3
err2025-07-25
err0
errOAAI
errR. Jeselsohn; J. Fu; Y. Ren; R. Mahtani; C. Ma; A. DeMichele; M. Cristofanilli; J. Meisel; K.D. Miller; Y. Abdou; E.C. Riley; R. Qamar; P. Sharma; S. Reid; N. Ko; Y. Liu; E. Gauthier; H.J. Burstein; M. DeMeo; M. Regan; S.M. Tolaney; E.L. Mayer
errShare
errSave
TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer
errTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
err2025-04-17
err0
errOAAI
errPeter Schmid; Mafalda Oliveira; Joyce O’Shaughnessy; Massimo Cristofanilli; Stephanie L. Graff; Seock-Ah Im; Sherene Loi; Shigehira Saji; Shusen Wang; David W. Cescon; Tina Hovey; Agata Nawrot; Karson Tse; Petra Vukovic; Giuseppe Curigliano
errShare
errSave
MGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancer
errNATURE COMMUNICATIONS
IF15.7
err2025-04-15
err0
errOAAI
errChi, Junlong Jack; Xie, Ping; Cheng, Mary Hongying; Zhu, Yueming; Cui, Xin; Watson, Joshua; Zeng, Lidan; Uddin, Amad; Nguyen, Hoang; Li, Lei; Moremen, Kelley; Reedy, April; Wyatt, Megan; Marcus, Adam; Dai, Mingji; Paulos, Chrystal M.; Cristofanilli, Massimo; Gradishar, William J.; Zhao, Shaying; Kalinsky, Kevin; Hung, Mine-Chie; Bahar, Ivet; Zhang, Bin
errShare
errSave
Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer
errJAMA NETWORK OPEN
IF9.7
err2025-02-26
err1
errOAAI
errPodany, Emily L.; Foffano, Lorenzo; Gerratana, Lorenzo; Medford, Arielle J.; Clifton, Katherine; Tapiavala, Shaili; Velimirovic, Marko; Lipsyc-Sharf, Marla; Reduzzi, Carolina; Bubie, Adrian; Putur, Annika; Ademuyiwa, Foluso O.; Puglisi, Fabio; Gradishar, William J.; Ma, Cynthia X.; Bardia, Aditya; Cristofanilli, Massimo; Davis, Andrew A.
errShare
errSave
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find them
errBREAST
IF7.9
err2025-02-01
err0
errOAAI
errFoffano, L.; Cucciniello, L.; Nicolo, E.; Migliaccio, I.; Noto, C.; Reduzzi, C.; Malorni, L.; Cristofanilli, M.; Gerratana, L.; Puglisi, F.; Pitigliani, Sandro
errShare
errSave
Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling
errCANCER LETTERS
IF10.1
err2025-01-01
err0
PREAI
errGerratana, Lorenzo; Davis, Andrew A.; Foffano, Lorenzo; Reduzzi, Carolina; Rossi, Tania; Medford, Arielle; Clifton, Katherine; Shah, Ami N.; Bucheit, Leslie; Velimirovic, Marko; Bandini, Sara; Dai, Charles S.; Wehbe, Firas; Gradishar, William J.; Behdad, Amir; Ulivi, Paola; Ma, Cynthia X.; Puglisi, Fabio; Bardia, Aditya; Cristofanilli, Massimo
errShare
errSave
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-12-01
err0
PREAI
errValenza, Carmine; Trapani, Dario; Zagami, Paola; Antonarelli, Gabriele; Bielo, Luca Boscolo; Nicolo, Eleonora; Ribeiro, Joana Mourato; Guidi, Lorenzo; Reduzzi, Carolina; Spotti, Martina; Adamoli, Laura; Cortes, Javier; Pistilli, Barbara; Tolaney, Sara M.; Ueno, Naoto; Layman, Rachel M.; Cristofanilli, Massimo; Carey, Lisa A.; Munzone, Elisabetta; Criscitiello, Carmen; Lynce, Filipa; Woodward, Wendy A.; Curigliano, Giuseppe
errShare
errSave
[18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases
errEUROPEAN JOURNAL OF RADIOLOGY
IF3.3
err2024-12-01
err0
PREAI
errIvanidze, Jana; Sharbatdaran, Arman; McCalla, Aliah; Brandmaier, Andrew; Andreopoulou, Eleni; Cristofanilli, Massimo; Cigler, Tessa; Balogun, Onyinye D.; Magge, Rajiv S.; Liechty, Benjamin; Karakatsanis, Nicolas A.; Nehmeh, Sadek A.; Agee, Matthew A.; Jean, Jolie; Osborne, Joseph R.; Beal, Kathryn; Schwartz, Theodore H.; Pannullo, Susan C.; Knisely, Jonathan P. S.; Ramakrishna, Rohan
errShare
errSave
Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors
errCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
IF5.6
err2024-11-01
err0
PREAI
errReduzzi, Carolina; Nicolo', Eleonora; Singhal, Surbhi; Venetis, Konstantinos; Ortega-Franco, Ana; de Miguel-Perez, Diego; Dipasquale, Angelo; Gouda, Mohamed A.; Saldanha, Erick F.; Kasi, Pashtoon M.; Jantus-Lewintre, Eloisa; Fusco, Nicola; Malapelle, Umberto; Gandara, David R.; Rolfo, Christian; Serrano, Maria Jose; Cristofanilli, Massimo
errShare
errSave
Prognostic and therapeutic implications of tumor-restrictive type III collagen in the breast cancer microenvironment
errNPJ BREAST CANCER
IF7.6
err2024-10-02
err1
errOAAI
errStewart, Daniel C.; Brisson, Becky K.; Dekky, Bassil; Berger, Ashton C.; Yen, William; Mauldin, Elizabeth A.; Loebel, Claudia; Gillette, Deborah; Assenmacher, Charles-Antoine; Quincey, Corisa; Stefanovski, Darko; Cristofanilli, Massimo; Cukierman, Edna; Burdick, Jason A.; Borges, Virginia F.; Volk, Susan W.
errShare
errSave
Mutant KRAS in Circulating Tumor DNA Assessed by Digit Droplet PCR as a Biomarker in Pancreatic Cancer in Patients Treated with Neoadjuvant Chemotherapy
errCANCER RESEARCH
IF16.6
err2024-09-15
err0
PREAI
errVitello, Dominic; Shah, Dhavan; Wells, Amy; Masnyk, Larissa; Cox, Madison; Janczewski, Lauren; Abad, John; Dawravoo, Kevin; D'Souza, Arlene; Suh, Grace; Bayer, Robert; Cristofanilli, Massimo; Bentrem, David; Liu, Yingzhe; Zhang, Hui; Santana-Santos, Lucas; Jennings, Lawrence; Zhang, Qiang; Chawla, Akhil
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
M Snyder
H-index: 210 · Papers: 3.3K
G
Gabriel N. Hortobágyi
H-index: 187 · Papers: 1.9K
J
Joel Schwartz
H-index: 181 · Papers: 1.4K
F
Fabrice André
H-index: 148 · Papers: 1.8K
F
Funda Meric‐Bernstam
H-index: 146 · Papers: 2.6K
View more